FDA Inspection 1088430 — Biotest Pharmaceuticals Corp.
The FDA completed an inspection of Biotest Pharmaceuticals Corp. on April 8, 2019 in Orlando, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 8, 2019
- Fiscal Year
- 2019
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Orlando, FL (United States)